Clincosm LogoSign in Get a demo

npc

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NPC Trial in Guangzhou (Sintilimab, IBI310)

Active, not recruiting
  • NPC
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 3, 2022

IMRT vs 2DRT for NPC Patients

Completed
  • NPC
  • IMRT
  • 2DRT
  • Hong Kong, Hong Kong
    The Chinese University of Hong Kong
Oct 21, 2021

NPC Trial in Hong Kong, Singapore (Pembrolizumab)

Recruiting
  • NPC
  • Hong Kong, Hong Kong
  • +1 more
Jul 26, 2021

Plasma EBV DNA Monitoring in Post-treatment NPC Patients

Completed
  • Nasopharyngeal Carcinoma
  • +3 more
    • Taichung, Taiwan
      Taichung Veterans General Hospital
    Jun 6, 2019

    Cisplatin, Carboplatin, NPC Trial in Guangzhou (Docetaxel,Carboplatin, Docetaxel,Cisplatin, Carboplatin-based concurrent

    Recruiting
    • Cisplatin
    • +2 more
    • Guangzhou, Guangdong, China
      Southern medical university
    Apr 14, 2019

    NPC Trial in Zhunan (Epigallocatechin Gallate (EGCG), Placebo)

    Unknown status
    • NPC
    • Epigallocatechin Gallate (EGCG)
    • Placebo
    • Zhunan, Miaoli, Taiwan
      Taiwan Cooperative Oncology Group, National Health Research Inst
    Sep 13, 2018

    NPC, Refractory Tumor Trial in Singapore (OPB-111077)

    Unknown status
    • NPC
    • Refractory Tumor
    • Singapore, Singapore
      National University Hospital, Singapore
    Jun 14, 2017